Abbott Laboratories Gains Access to Expanded European Market with Navitor System

Clinical Expansion and Market Implications

A significant regulatory milestone in Europe has positioned Abbott Laboratories for accelerated growth within its structural heart business. The medical device giant’s Navitor transcatheter aortic valve implantation (TAVI) system recently received expanded approval from European authorities, dramatically increasing its potential patient population and opening access to a substantially larger market.